Akura Medical Closes $25M Series A1 Financing

Akura Medical

Akura Medical, Inc., a Campbell, Calif.-based medtech company, closed its $25M Series A1 financing.

The financing was led by Cormorant Asset Management, with participation from The Capital Partnership (TCP), PA MedTech VC Fund and Shifamed angel investors.

The Shifamed portfolio company intends to use the funds for the development of its thrombectomy device.

Akura Medical is developing a next generation thrombectomy device that aims to simplify thrombectomy through a single pass procedure that efficiently removes blood clots.